<DOC>
	<DOCNO>NCT03067298</DOCNO>
	<brief_summary>Preterm birth ( PTB ) , preeclampsia ( PE ) , fetal growth restriction ( FGR ) intra-uterine fetal death ( IUFD ) constitute main cause perinatal morbidity mortality call `` Great Obstetrical Syndromes '' . Algorithms predict outcome develop combine maternal characteristic ( history , age , BMI , blood pressure ) , biochemical ( sFlt-1 , β-hCG , PlGF , AFP ) sonographic ( uterine artery Doppler , 3D placenta , cervical length , nasal bone measurement , nuchal translucency ) marker . Another prospective observational study ( `` PREDICTION study '' NCT 02189148 ) also ongoing , aim validate algorithm first trim pregnancy . Recent data suggest repeating measurement later pregnancy could improve detection rate , allow closer monitoring high-risk patient potential therapeutic investigation . The current study ( PREDICTION2 ) ancillary study PREDICTION aim validate use marker combine iterative manner prediction preeclampsia obstetrical outcome .</brief_summary>
	<brief_title>Prediction Preeclampsia Other Pregnancy Complications Following Combined Iterative Screening</brief_title>
	<detailed_description>The objective study validate predictive value biophysical ( maternal blood pressure ) ; biochemical ( sFlt-1 , β-hCG , PlGF , AFP ) ultrasonographic ( cervical length , Doppler , 3D evaluation placenta , 3D nasal bone ) biomarkers several timepoints prediction adverse pregnancy outcome include preterm birth , preeclampsia , fetal growth restriction intra-uterine fetal death . These biomarkers evaluate 14-16 week , 20-24 week 30-34 week . Those specific gestational age select correspond typical clinical/hospital visit prenatal blood and/or ultrasound screening .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Pregnancy Complications</mesh_term>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<mesh_term>Fetal Death</mesh_term>
	<mesh_term>Stillbirth</mesh_term>
	<criteria>nulliparous pregnant woman participate Prediction study ( NCT02189148 ) &lt; 18 year old recruitment ; multiple pregnancy ; fetal congenital malformation ; positive HIV hepatitis C ; fetal demise recruitment ; woman plan delivery outside participate hospital ; woman able provide inform consent study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>pregnancy</keyword>
	<keyword>screen</keyword>
	<keyword>doppler</keyword>
	<keyword>marker</keyword>
	<keyword>PlGF</keyword>
	<keyword>sFlt-1</keyword>
	<keyword>placenta</keyword>
</DOC>